ULK4 (Unc-51 Like Kinase 4) is a serine/threonine kinase that plays a significant role in the regulation of various cellular processes, including neurogenesis, the development of the central nervous system, and possibly the regulation of ciliogenesis and autophagy. As a relatively less characterized member of the ULK family, ULK4's precise mechanisms of action and its full spectrum of biological functions are still under investigation. However, it is known to be involved in the intricate signaling pathways that govern cell proliferation, differentiation, and survival, particularly within the neural context. The kinase's unique structure and expression pattern suggest that it could have specialized functions in neuronal development and in maintaining the homeostasis of neural cells. Its involvement in these critical processes indicates that ULK4 could play a key role in the etiology of various neurodevelopmental disorders and diseases related to the malfunctioning of neural processes.
The inhibition of ULK4 involves targeting its kinase activity, which is central to its role in signaling pathways. Inhibitors of ULK4 may act by directly binding to the kinase domain, thereby preventing ATP binding and phosphorylation activity. This action would effectively halt the kinase's ability to phosphorylate target proteins, thus disrupting the downstream signaling pathways in which ULK4 is involved. Alternatively, indirect mechanisms of inhibition could involve modulating the expression levels of ULK4 or affecting its interaction with other proteins in the cell, thereby influencing its functional activity. Given the kinase's involvement in neural development and possibly autophagy, the inhibition of ULK4 could have profound effects on cellular processes that are critical for normal development and maintenance. Understanding these inhibitory mechanisms is crucial for elucidating the physiological and pathological roles of ULK4, as well as for exploring potential interventions in diseases associated with its dysregulation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor, staurosporine can inhibit a wide range of kinases, potentially affecting ULK4 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, LY294002 can disrupt signaling pathways that may indirectly modulate ULK4's kinase activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor SP600125 can alter signaling pathways, which may influence ULK4's role in cellular processes. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
An adenosine kinase inhibitor that can increase intracellular adenosine, potentially affecting ULK4's kinase domain. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Cyclin-dependent kinase inhibitor that might alter cell cycle-related pathways, with possible effects on ULK4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can disrupt autophagy pathways, where ULK4 might play a role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that could indirectly affect ULK4 activity by modulating related pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor that can influence various signaling cascades, potentially affecting ULK4. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that might indirectly modulate ULK4's function within stress response pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor that can influence MAPK/ERK pathways, which might interact with ULK4's signaling. | ||||||